Bengaluru: The doctor has the top new antivirus drug molnupiravir, launched on January 3 to treat Covid-19, after recent comments by ICMR for the safety of the drug.
The doctor has now urged ICMR to clean the air.
ICMR said the drug could have a negative impact on the development of unborn children.
If a patient takes Molnupiravir, they (both men and women) do not need to use contraception ive for three months, because a child conceived during the period can be affected, I CMR has warned.
Karnataka clinical advisory committee members for Covid said the drug should not be prescribed for people in the reproductive age group, UT safe for certain patients.
“Why are these problems raised while approving 21 companies that produce carpets in India or when controlling D carpet General India (DCGI) approved the carpet D?” Said Dr.
Satyanarayan a Mysore, Hod, Pulmonology, Manipal Hospitals, which H as stopped prescribing the carpet D.
“ICMR must issue clarification D seconds to clean it The medicine concluded that “early treatment with Molnupiravir reduces the risk of hospitalization or death in risk, adults who are not vaccinated with Covid-19”.
“This drug is used in the UK and the US.
Does ICMR consider all these facts before stating that it has security issues?” Request members of the Technical Advisory Committee.
Dr.
MySore added: “We cannot prescribe it now because the patient shows that ICMR has filed an objection.
ICMR must issue clarification and take proactive action by talking with DCGI, and the Indian government.” Many hospitals have used drugs during the past week, but use now almost stopped.
“After ICMR was worrying, we stopped prescribing it,” said Dr.
Pruthu Narendra Dhekanan, consultant, infectious disease, Fortis Hospital, Bannerghatta Road.
“We use it at six or seven patients who are definitely outside the reproductive age group.” Dr.
Ravindra Mehta, Lung Head, Critical Care, and Intervention, Special Hospital Apollo, said the drug was only used in certain groups that did not include children Under 18 years old, nursing mothers or children plan to get pregnant.
The source said Molnupiravir was recommended by the clinical expert committee as well, but only for risky patients (those who have comorbidity) and it will only be used in covid care centers.
No need to worry about Dr.
CN Manjuhanth, a member of the technical and clinical expert committee, said those who had taken the medicine should not worry.
“Not only molnupiravir, 99% of drugs throughout the specialization are not given to pregnant women,” said Dr.
Manjunath.
“I am sure the doctor will not prescribe the medicine to a pregnant woman who is infected.
It is only a five-day drug to reduce symptoms.
This drug was released on the market after clinical trial and scientific research.”